The use of neoadjuvant chemotherapy in patients with pancreatic cancer undergoing pancreatic resection was found to be associated with lower postoperative hospital readmission.
Neoadjuvant Therapy Before Pancreatic Cancer Surgery Reduces Readmission
Jordan Litaker2021-03-16T10:59:40+00:00February 11th, 2021|Uncategorized|Comments Off on Neoadjuvant Therapy Before Pancreatic Cancer Surgery Reduces Readmission